ARCHIVES

FDA Ponders Standards For “Retrospective Prospective” Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 04 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

NCI to Study Review Group’s report Urging Restructure of Prevention Programm

June 27, 1997

In Congress: Time Running out On Effort To Double Market Exclusivity Term

November 7, 1997

PET Better At Evaluating Response In Sarcoma

February 29, 2008

Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity

October 28, 2011

NIH Deputy Director Ruth Kirschstein Plans Transition To Senior Advisor

October 4, 2002

Cancer Centers Win Majority Of Grants In Recent NCI RFAs, Klausner Tells AACI.

October 6, 2000